AZN 6-K: Fda approval

AstraZeneca

Filed with the SEC on · accession 0001654954-26-009815

AZN filed a 6-K (foreign company report) with the SEC on Nov 16, 2026. AstraZeneca announced that its drug Baxfendy (baxdrostat) received a positive CHMP opinion recommending EU approval for treating adults with hypertension insufficiently controlled by at least two antihypertensive medicines.

Summary of the filing

AstraZeneca announced that its drug Baxfendy (baxdrostat) received a positive CHMP opinion recommending EU approval for treating adults with hypertension insufficiently controlled by at least two antihypertensive medicines. If approved, it would be the first and only aldosterone synthase inhibitor in the EU.

Key details

IssuerAstraZeneca PLC
Regulatory bodyEuropean Medicines Agency (EMA)
Regulatory committeeCommittee for Medicinal Products for Human Use (CHMP)
Executive vice president and president, biopharmaceuticals business unit, astrazenecaRuud Dobber
Chair of medicine at university college london and primary investigator for baxhtn and bax24Dr. Bryan Williams

✦ Ask GOAX AI about this filing — what it means for AZN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AZN?

Click here

Frequently asked questions

What did AZN file with the SEC on Nov 16, 2026?

AZN filed a 6-K (Fda approval). AstraZeneca announced that its drug Baxfendy (baxdrostat) received a positive CHMP opinion recommending EU approval for treating adults with hypertension insufficiently controlled by at least two antihypertensive medicines. If approved, it would be the first and only aldosterone synthase inhibitor in the EU.

What does a fda approval mean for AZN stock?

For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other AZN SEC filings

Get alerts when AZN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days